Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (12,785,000)	$ (20,038,000)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization of property, plant and equipment and software development costs	961,000	885,000
Amortization of intangible assets	8,452,000	5,103,000
Amortization of operating lease right-of-use assets	399,000	392,000
Provision for (recovery of) credit losses	340,000	(96,000)
Amortization of debt issuance costs and debt discount	2,564,000	1,951,000
Investment loss from investment in Eton Pharmaceuticals		3,171,000
Stock-based compensation	5,431,000	8,440,000
Deferred income tax		623,000
Changes in assets and liabilities:
Accounts receivable	37,211,000	(15,631,000)
Inventories	(850,000)	1,442,000
Prepaid expenses and other current assets	3,776,000	2,579,000
Accounts payable, accrued expenses, accrued rebates and copay assistance	(24,009,000)	3,361,000
Accrued payroll and related liabilities	(2,672,000)	271,000
Deferred revenue and customer deposits	47,000	173,000
NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES	18,865,000	(7,374,000)
CASH FLOWS FROM INVESTING ACTIVITIES
Net proceeds on sale of investment in Eton Pharmaceuticals		5,510,000
Investment in patent and trademark assets	(169,000)	(81,000)
Purchases of property, plant and equipment	(336,000)	(436,000)
NET CASH (USED IN) PROVIDED BY INVESTING ACTIVITIES	(505,000)	4,993,000
CASH FLOWS FROM FINANCING ACTIVITIES
Payment of payroll taxes upon vesting of PSUs, RSUs and exercise of stock options	(12,769,000)	(1,157,000)
Proceeds from exercise of stock options	125,000	521,000
Payment of debt issuance costs		(100,000)
NET CASH USED IN FINANCING ACTIVITIES	(12,644,000)	(736,000)
NET CHANGE IN CASH AND CASH EQUIVALENTS	5,716,000	(3,117,000)
CASH AND CASH EQUIVALENTS, beginning of period	47,247,000	74,085,000
CASH, CASH EQUIVALENTS, end of period	52,963,000	70,968,000
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Cash paid for income taxes	38,000
Cash paid for interest	12,180,000	10,316,000
SUPPLEMENTAL DISCLOSURES OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
Purchase of property, plant and equipment included in accounts payable and accrued expenses	130,000	44,000
Change in right-of-use assets for operating lease obligations assumptions		$ 377,000